Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The most common subtype of the myelodysplastic syndromes affecting children. It is characterized by persistent cytopenia with less than 5% blasts in the bone marrow and less than 2% blasts in the peripheral blood.
No clinical trials have been registered for refractory cytopenia of childhood.
9 publications have been identified in PubMed for refractory cytopenia of childhood. Research spans Review / Meta-Analysis (44%), Clinical Trial Publication (22%), and Epidemiology / Natural History (22%).
Fan Z (2026). [PMID: 42125547](https://pubmed.ncbi.nlm.nih.gov/42125547/). *Exp Ther Med*. [Case Report / Case Series]
Tegtmeyer D (2026). [PMID: 41363020](https://pubmed.ncbi.nlm.nih.gov/41363020/). *Journal of pediatric gastroenterology and nutrition*. [Epidemiology / Natural History]
Yoshida N (2025). [PMID: 41034069](https://pubmed.ncbi.nlm.nih.gov/41034069/). *[Rinsho ketsueki] The Japanese journal of clinical hematology*. [Review / Meta-Analysis]
Drexler B (2025). [PMID: 40554414](https://pubmed.ncbi.nlm.nih.gov/40554414/). *Blood advances*. [Epidemiology / Natural History]
Cammenga J (2024). [PMID: 38649131](https://pubmed.ncbi.nlm.nih.gov/38649131/). *Experimental hematology*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 8:59 PM UTC
Uria-Oficialdegui ML (2024). [PMID: 39227649](https://pubmed.ncbi.nlm.nih.gov/39227649/). *Bone marrow transplantation*. [Clinical Trial Publication]
Acar SO (2024). [PMID: 38741164](https://pubmed.ncbi.nlm.nih.gov/38741164/). *Scandinavian journal of immunology*. [Clinical Trial Publication]
Vinci L (2024). [PMID: 38993648](https://pubmed.ncbi.nlm.nih.gov/38993648/). *Frontiers in oncology*. [Review / Meta-Analysis]
Rao VK (2024). [PMID: 39644063](https://pubmed.ncbi.nlm.nih.gov/39644063/). *Hematology. American Society of Hematology. Education Program*. [Review / Meta-Analysis]